Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting.
Patricia C MazzonettoDarine VillelaSilvia Souza da CostaTalita Ferreira AguiarFernanda MilaneziMichele P MigliavaccaPaulo M PierryAdriano BonaldiLuiz Gustavo D AlmeidaCamila Alves De SouzaJosé Eduardo KrollMarcelo G PaulaRodrigo Guarischi-SousaCristovam Scapulatempo-NetoCarla RosenbergPublished in: Annals of human genetics (2023)
Our data show the potential use of LP-WGS to detect CNVs in clinical diagnosis and confirm the method as an alternative for chromosome imbalances detection. The diagnostic effectiveness and feasibility of LP-WGS, in this technical validation study, were evidenced by a clinically representative dataset of CNVs that allowed a systematic assessment of the detection power and the accuracy of the sequencing approach. Further, since the software used in this study is commercially available, the method can easily be tested and implemented in a routine diagnostic setting.